Albers Jeffrey W. (CIK 0001638474)

Latest company ownership

Shares held
27,360
Last filed at
Nov 8, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2024Q4 2025Q4
Shares held
5,000
Last filed at
Oct 14, 2025
Confidence Score
10.6
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 8, 2025 Dec 8, 2025 Kymera Therapeutics, Inc. Director Sell 7.5 -5,000 -100.00% ✓ $448.8K
Oct 13, 2025 Oct 14, 2025 Kymera Therapeutics, Inc. Director Sell 7.5 -5,000 -100.00% ✓ $295.9K
Jun 3, 2025 Jun 3, 2025 Kymera Therapeutics, Inc. Director Sell 7.5 -6,349 -100.00% ✓ $311.1K
Nov 6, 2024 Nov 8, 2024 Spyre Therapeutics, Inc. Director Sell 20.0 -6,700 -19.67% ✓ $246.3K
Oct 25, 2024 Oct 28, 2024 Spyre Therapeutics, Inc. Director Sell 51.3 -300 -0.87% ✓ $10.9K
Aug 26, 2024 Aug 26, 2024 Kymera Therapeutics, Inc. Director Sell 10.0 -5,000 -100.00% ✓ $245.5K
Feb 20, 2024 Feb 21, 2024 Kymera Therapeutics, Inc. Director Sell 10.0 -5,000 -100.00% ✓ $195.3K
Jan 23, 2024 Jan 23, 2024 Kymera Therapeutics, Inc. Director Sell 7.5 -10,000 -100.00% ✓ $300.5K